PTAB.US: Decisions of PTAB Patent Trial and Appeal Board Updated Daily.

Search This Blog

Loading...

Monday, March 7, 2016

par pharmaceutical, medichem

custom search

AFFIRMED-IN-PART
Tech Center 2100 Computer Architecture and Software
2123 Ex Parte Hoitsma et al 12501542 - (D) MacDONALD 103 103 41.50 101 PIETRAGALLO GORDON ALFANO BOSICK & RASPANTI, LLP CRAIG, DWIN M

AFFIRMED
Tech Center 1700 Chemical & Materials Engineering
1734 Ex Parte Leininger 13560957 - (D) RANGE 103 GE Power & Water Fletcher Yoder PC NASSIRI MOTLAGH, ANITA

Cf., e.g., PAR Pharm., Inc. v. TWI Pharms., Inc., 773 F.3d 1186, 1198 (Fed. Cir. 2014). (“The reasonable expectation of success requirement for obviousness does not necessitate an absolute certainty for success.”). Moreover, even if Van der Ploeg could result in some attrition, a person of ordinary skill in the art would nonetheless be motivated to combine Van der Ploeg’s continuous transport apparatus with Hoover’s system because of the many advantages of the Van der Ploeg apparatus explained above. Cf. Medichem, S.A. v. Rolabo, S.L., 437 F.3d 1157, 1165 (Fed. Cir. 2006) (“a given course of action often has simultaneous advantages and disadvantages, and this does not necessarily obviate motivation to combine”).

Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3659 Ex Parte Harter et al 12566363 - (D) STEPINA 102/103 Muncy, Geissler, Olds & Lowe, P.C. SCOTT, JACOB S

No comments :